Terms: = Liver cancer AND RUNX1T1, ENSG00000079102, 862
152 results:
1. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulation of the Skin-liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis.
Marani M; Madan V; Le TK; Deng J; Lee KK; Ma EZ; Kwatra SG
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397136
[TBL] [Abstract] [Full Text] [Related]
3. Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC.
Cai Q; Li G; Zhu M; Zhuo T; Xiao J
J Cancer Res Clin Oncol; 2024 Feb; 150(2):86. PubMed ID: 38334792
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
Kim JI; Lee J; Choi GH; Lee MW; Park DA; Yoo JJ
Dig Dis Sci; 2024 Mar; 69(3):1055-1067. PubMed ID: 38300416
[TBL] [Abstract] [Full Text] [Related]
5. The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis.
Li D; Zhang C; Yang K; Ma Z; Ma L; Cheng C; Xu L; Wan S
Medicine (Baltimore); 2024 Jan; 103(3):e36865. PubMed ID: 38241568
[TBL] [Abstract] [Full Text] [Related]
6. Complication Rates and Risk of Recurrence After Percutaneous Radiofrequency Ablation and Microwave Ablation for the Treatment of liver Tumors: a Meta-analysis.
Alhasan AS; Daqqaq TS; Alhasan MS; Ghunaim HA; Aboualkheir M
Acad Radiol; 2024 Apr; 31(4):1288-1301. PubMed ID: 38087720
[TBL] [Abstract] [Full Text] [Related]
7. Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy.
Zhao CK; Guan X; Pu YY; Zhou BY; Wang LF; Sun YK; Yin HH; Xia HS; Wang X; Han H; Xu HX
Ultrasound Med Biol; 2024 Jan; 50(1):142-149. PubMed ID: 37852872
[TBL] [Abstract] [Full Text] [Related]
8. A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma.
Liu MT; Zhang JY; Xu L; Qu Q; Lu MT; Jiang JF; Zhao XC; Zhang XQ; Zhang T
Radiol Med; 2023 Nov; 128(11):1333-1346. PubMed ID: 37740839
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
[TBL] [Abstract] [Full Text] [Related]
10. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
[TBL] [Abstract] [Full Text] [Related]
11. A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study.
Yoshida H; Ohki T; Kanezaki M; Teratani T; Sato S; Obi S; Sato T; Akamatsu M; Uchino K; Taniguchi H
BMC Gastroenterol; 2023 Jul; 23(1):250. PubMed ID: 37488476
[TBL] [Abstract] [Full Text] [Related]
12. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
[TBL] [Abstract] [Full Text] [Related]
13. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
Zhang PR; Ma XL; Guo L; Lu RQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
[No Abstract] [Full Text] [Related]
14. Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
Oosterom N; Gooskens SLM; Renfro LA; Perlman EJ; van den Heuvel-Eibrink MM; Hamilton TE; Green DM; Grundy PE; Daw NC; Geller JI; Dome JS; Fernandez CV; Mullen EA
J Clin Oncol; 2023 Sep; 41(26):4247-4256. PubMed ID: 37343199
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Characteristics Associated With Posttransplant Survival Among Adults 70 Years Old or Older Undergoing liver Transplantation.
Wang M; Ge J; Ha N; Shui AM; Huang CY; Cullaro G; Lai JC
J Clin Gastroenterol; 2024 May-Jun 01; 58(5):516-521. PubMed ID: 37279205
[TBL] [Abstract] [Full Text] [Related]
16. Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma.
Yang R; Yu X; Zeng P
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10099-10108. PubMed ID: 37266663
[TBL] [Abstract] [Full Text] [Related]
17. Regional disparities in cancer survival in Iran: Insight from a National Surveillance of cancer Survival in Iran (IRANCANSURV).
Nemati S; Saeedi E; Lotfi F; Nahvijou A; Pirnejad H; Cheraghi M; Rezaeianzadeh A; Dolatkhah R; Bazarafshan A; Golpazir A; Yaghoobi-Ashrafi M; Abdi S; Alvand S; Ravankhah Z; Mohebbi E; Khosravi A; Etemadi A; Sheikh M; Roshandel G; Ghanbari-Motlagh A; Partovipour E; Najafi F; Malekzadeh R; Mohagheghi MA; Zendehdel K
Cancer Epidemiol; 2023 Aug; 85():102378. PubMed ID: 37229955
[TBL] [Abstract] [Full Text] [Related]
18. A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.
Zhou Q; Zhan Y; Guo J
BMC Gastroenterol; 2023 May; 23(1):177. PubMed ID: 37221487
[TBL] [Abstract] [Full Text] [Related]
19. Respiratory-Correlated 4-Dimensional Magnetic Resonance Fingerprinting for liver cancer Radiation Therapy Motion Management.
Liu C; Li T; Cao P; Hui ES; Wong YL; Wang Z; Xiao H; Zhi S; Zhou T; Li W; Lam SK; Cheung AL; Lee VH; Ying M; Cai J
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):493-504. PubMed ID: 37116591
[TBL] [Abstract] [Full Text] [Related]
20. The Natural History of Pancreatic Cystic Lesions in liver Transplant Recipients: A Systematic Review and Meta-analysis.
Canakis A; Vittal A; Deliwala S; Twery B; Canakis J; Patel P; Chahal P
Pancreas; 2022 Oct; 51(9):1160-1166. PubMed ID: 37078940
[TBL] [Abstract] [Full Text] [Related]
[Next]
